BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14602801)

  • 1. Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients.
    Gonzalez A; Abril E; Roca A; Aragón MJ; Figueroa MJ; Velarde P; Ruiz R; Fayez O; Galán JJ; Herreros JA; Real LM; Ruiz A
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5529-36. PubMed ID: 14602801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome.
    Wiltgen D; Furtado L; Kohek MB; Spritzer PM
    Gynecol Endocrinol; 2007 Mar; 23(3):173-8. PubMed ID: 17454172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment: CAPN10 alleles are associated with polycystic ovary syndrome.
    Gonzalez A; Abril E; Roca A; Aragón MJ; Figueroa MJ; Velarde P; Royo JL; Real LM; Ruiz A
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3971-6. PubMed ID: 12161543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women.
    Márquez JL; Pacheco A; Valdés P; Salazar LA
    Clin Chim Acta; 2008 Dec; 398(1-2):5-9. PubMed ID: 18722363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific haplotypes of the CALPAIN-5 gene are associated with polycystic ovary syndrome.
    González A; Sáez ME; Aragón MJ; Galán JJ; Vettori P; Molina L; Rubio C; Real LM; Ruiz A; Ramírez-Lorca R
    Hum Reprod; 2006 Apr; 21(4):943-51. PubMed ID: 16396936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CAPN10 SNPs and haplotypes with polycystic ovary syndrome among South Indian Women.
    Dasgupta S; Sirisha PV; Neelaveni K; Anuradha K; Reddy BM
    PLoS One; 2012; 7(2):e32192. PubMed ID: 22384174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common polymorphisms of calpain-10 and the risk of polycystic ovary syndrome in Tunisian population: a case-control study.
    Ben Salem A; Attaoua R; Mtiraoui N; Belkahla S; Ezzidi I; Ajina M; Souissi M; Poucheret P; Vintila M; Grigorescu F; Mahjoub T
    Mol Biol Rep; 2014 Oct; 41(10):6569-74. PubMed ID: 24993116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians.
    Vollmert C; Hahn S; Lamina C; Huth C; Kolz M; Schöpfer-Wendels A; Mann K; Bongardt F; Mueller JC; Kronenberg F; Wichmann HE; Herder C; Holle R; Löwel H; Illig T; Janssen OE;
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E836-44. PubMed ID: 17106059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association analysis of SNP-63 and indel-19 variant in the calpain-10 gene with polycystic ovary syndrome in women of reproductive age].
    Flores-Martínez SE; Castro-Martínez AG; López-Quintero A; García-Zapién AG; Torres-Rodríguez RN; Sánchez-Corona J
    Cir Cir; 2015; 83(1):35-42. PubMed ID: 25982606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Calpain (CAPN) 10 (UCSNP-43, rs3792267) gene polymorphism with elevated serum androgens in young women with the most severe phenotype of polycystic ovary syndrome (PCOS).
    Anastasia K; Koika V; Roupas ND; Armeni A; Marioli D; Panidis D; George A; Georgopoulos NA
    Gynecol Endocrinol; 2015; 31(8):630-4. PubMed ID: 26376770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 111/121 diplotype of Calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women.
    Lee JY; Lee WJ; Hur SE; Lee CM; Sung YA; Chung HW
    Fertil Steril; 2009 Aug; 92(2):830-3. PubMed ID: 18701098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome.
    Haddad L; Evans JC; Gharani N; Robertson C; Rush K; Wiltshire S; Frayling TM; Wilkin TJ; Demaine A; Millward A; Hattersley AT; Conway G; Cox NJ; Bell GI; Franks S; McCarthy MI
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2606-10. PubMed ID: 12050223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies.
    Song Y; Niu T; Manson JE; Kwiatkowski DJ; Liu S
    Am J Hum Genet; 2004 Feb; 74(2):208-22. PubMed ID: 14730479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
    Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH
    Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain-5 gene variants are associated with diastolic blood pressure and cholesterol levels.
    Sáez ME; Martínez-Larrad MT; Ramírez-Lorca R; González-Sánchez JL; Zabena C; Martinez-Calatrava MJ; González A; Morón FJ; Ruiz A; Serrano-Ríos M
    BMC Med Genet; 2007 Jan; 8():1. PubMed ID: 17227582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-existence of risk and protective haplotypes of Calpain 10 gene to type 2 diabetes in the eastern Indian population.
    Adak S; Sengupta S; Chowdhury S; Bhattacharyya M
    Diab Vasc Dis Res; 2010 Jan; 7(1):63-8. PubMed ID: 20368234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a protective haplogenotype within CAPN10 gene influencing colorectal cancer susceptibility.
    Frances CP; Conde MC; Saez ME; Diez SF; Rey CM; Ramírez-Armengol JA; Pascual MH; Gonzalez-Perez A; Torres PP; Real LM; Serrano-Rios M; López JL; Ruiz A; Royo JL
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2298-302. PubMed ID: 17559371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor gene (CAG)n polymorphism in patients with polycystic ovary syndrome.
    Ferk P; Perme MP; Teran N; Gersak K
    Fertil Steril; 2008 Sep; 90(3):860-3. PubMed ID: 18555222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.
    Maier PS; Spritzer PM
    Gynecol Obstet Invest; 2012; 74(2):136-42. PubMed ID: 22889864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
    Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.